Nafamostat Mesylate Protects Against Acute Renal Ischemia–Reperfusion Injury by Alleviating Mitochondrial Dysfunction, Inhibiting Ferroptosis, and Regulating Proximal Tubular Cells: A Multi‐Omics Analysis
NM protects against AKI by reducing reactive oxygen species, upregulating fatty acids, and regulating ferroptosis signaling pathways in proximal tubular cells.
Authors
- Santao Ou (ORCID: https://orcid.org/0000-0003-2806-4025)
- Hanfeng Li
- YuHan Wang
- Y Li
- B. Chen
- Huameng Xing
- jiang liu
- Yuxuan Wu (ORCID: https://orcid.org/0009-0007-6938-9009)
- Qiaoyu Wang (ORCID: https://orcid.org/0009-0009-9708-0273)
- Weihua Wu
- Lan Huang
- Ling Xue
- Dongmei Zhang
Institutions
- Chengdu Medical College (CN)
- Southwest Medical University (CN)
- Affiliated Hospital of Southwest Medical University (CN)
- Chengdu Fifth People's Hospital (CN)
- Zigong First People's Hospital (CN)
Publication Details
- Journal
- Therapeutic Apheresis and Dialysis
- Published
- 2025-12-23
- DOI
- https://doi.org/10.1002/1744-9987.70112
- Primary Topic
- Ferroptosis and cancer prognosis
- Type
- article
- Field-Weighted Citation Impact
- 0.00